Numis Securities Ltd Reiterates “Buy” Rating for NMC Health PLC (NMC)
NMC Health PLC (LON:NMC)‘s stock had its “buy” rating reaffirmed by analysts at Numis Securities Ltd in a research report issued to clients and investors on Friday, AR Network reports. They currently have a GBX 500 ($8.09) target price on the stock. Numis Securities Ltd’s price target suggests a potential upside of 38.24% from the stock’s previous close.
NMC Health PLC (LON:NMC) traded down 1.71% on Friday, hitting GBX 361.70. The stock had a trading volume of 19,868 shares. NMC Health PLC has a 52 week low of GBX 166.739 and a 52 week high of GBX 373.60. The stock’s 50-day moving average is GBX 335.4 and its 200-day moving average is GBX 312.3.
Separately, analysts at Jefferies Group initiated coverage on shares of NMC Health PLC in a research note to investors on Monday, September 16th. They set a “buy” rating and a GBX 430 ($6.96) price target on the stock.
NMC Health plc is a holding company. The Company is an integrated healthcare provider in the United Arab Emirates market.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.